A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms

Completed · Not applicable

Conditions studied: Intervention

In brief

This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.

Key facts

Study ID

NCT04035499

Run by

University of Rochester

People needed

25

Starts

2020-02-01

Expected to finish

2021-10-31

Last updated by the study team

2026-03-31

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age is greater than or equal to 60 years
• Have a diagnosis of MN
• Receiving outpatient chemotherapy (e.g., HMA)
• English speaking
• Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
• No medical contraindications for exercise per oncologist
• Able to walk 4 meters as part of Short Physical Performance Battery measured walk (with or without assistive device)
• Able to provide informed consent

You may not qualify if…

• Platelet count of 10,000 per microliter or less in the most recent blood draw (due to risk of spontaneous bleeding) prior to transfusion (i.e., patients are allowed to enroll if their platelet count is 10,000 per microliter or less but is scheduled to receive transfusion the day of consent)

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.